No Data
No Data
10 Health Care Stocks Whale Activity In Today's Session
Pony AI, Hims & Hers And Frontdoor Are Among Top 11 Mid-Cap Gainers Last Week (Apr 28-May 2): Are The Others In Your Portfolio?
Kiniksa Pharmaceuticals International Insider Sold Shares Worth $2,347,335, According to a Recent SEC Filing
3 Stocks Including Kiniksa Pharmaceuticals International That May Be Priced Below Intrinsic Value Estimates
An Intrinsic Calculation For Kiniksa Pharmaceuticals International, Plc (NASDAQ:KNSA) Suggests It's 41% Undervalued
Jefferies Maintains Kiniksa Pharmaceuticals International(KNSA.US) With Buy Rating, Raises Target Price to $45